Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000704965 | SCV000833940 | uncertain significance | Fanconi anemia | 2022-06-09 | criteria provided, single submitter | clinical testing | This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 430 of the FANCA protein (p.Ala430Val). This variant is present in population databases (rs772567344, gnomAD 0.007%). This missense change has been observed in individual(s) with clinical features of FANCA-related conditions (PMID: 34573280). ClinVar contains an entry for this variant (Variation ID: 581207). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0". The valine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Natera, |
RCV000704965 | SCV002095050 | uncertain significance | Fanconi anemia | 2021-01-07 | no assertion criteria provided | clinical testing |